*Infinity Pharmaceuticals Inc, Pharmacyclics: Goldman starts with neutral- Theflyonthewall.com.
Feb 21- Abbott Laboratories said on Thursday it was working with Johnson& Johnson to see if a genetic diagnostic test made by Abbott would help to identify patients most likely to benefit from a promising experimental leukemia treatment.